Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood

Haematologica

Volumn 99, Issue 4, 2014, Pages 656-663

  Yoshimi, Ayami ^a   van den Heuvel Eibrink, Marry M ^b   Baumann, Irith ^c   Schwarz, Stephan ^d   Simonitsch Klupp, Ingrid ^e   de Paepe, Pascale ^f   Campr, Vit ^g   Kerndrup, Gitte Birk ^h   O'Sullivan, Maureen ⁱ   Devito, Rita ^j   Leguit, Roos ^k   Hernandez, Miguel ^l   Dworzak, Michael ^e   de Moerloose, Barbara ^f   Starý, Jan ^g   Hasle, Henrik ^m   Smith, Owen P ⁱ   Zecca, Marco ⁿ   Catala, Albert ^o   Schmugge, Markus ^p   Locatelli, Franco ^q   Führer, Monika ^r   Fischer, Alexandra ^a   Guderle, Anne ^a   Nöllke, Peter ^a   Strahm, Brigitte ^a   Niemeyer, Charlotte M ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c Institute of Pathology   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^h LILLEBAELT HOSPITAL   (Denmark)

ⁱ OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^j BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l HOSPITAL UNIVERSITARIO LA FE   (Spain)

^m AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁿ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^o HOSPITAL SANT JOAN DE DÉU   (Spain)

^p UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^q UNIVERSITY OF PAVIA   (Italy)

^r LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME ABERRATION; CLONAL EVOLUTION; COMPARATIVE STUDY; CYTOPENIA; DEATH; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HORSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; RABBIT; REFRACTORY CYTOPENIA; RELAPSE; SCHOOL CHILD; SURVIVAL RATE; TREATMENT RESPONSE; ANIMAL; CLINICAL TRIAL; PANCYTOPENIA; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ANIMALS; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; FEMALE; HORSES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PANCYTOPENIA; RABBITS; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84897425505     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.095786     Document Type: Article

References (37)

1. Baumann I, Niemeyer CM, Benett J. Childhood myelodysplastic syndrome. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:104-7.
2. Niemeyer CM, Baumann I. Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program. 2011;2011:84-9.
3. Smith MA, Smith JG. The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leuk Res. 1991;15 (7):597-601.
4. Sugawara T, Endo K, Shishido T, Sato A, Kameoka J, Fukuhara O, et al. T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes. Am J Hematol. 1992;41 (4): 304-5.
5. Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFUGM and alterations in T-cell receptor Vbeta profiles. Br J Haematol. 1998;102(5):1314-22.
6. Kochenderfer JN, Kobayashi S, Wieder ED, Su C, Molldrem JJ. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood. 2002;100(10): 3639-45.
7. Sloand EM, Melenhorst JJ, Tucker ZC, Pfannes L, Brenchley JM, Yong A, et al. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy. Blood. 2011; 117(9):2691-9.
8. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol. 2000;37(1):15-29.
9. Molldrem JJ, Leifer E, Bahceci E, Saunthararajah Y, Rivera M, Dunbar C, et al. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann Intern Med. 2002;137(3):156-63.
10. Stadler M, Germing U, Kliche KO, Josten KM, Kuse R, Hofmann WK, et al. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia. 2004;18(3): 460-5.
11. Lim ZY, Killick S, Germing U, Cavenagh J, Culligan D, Bacigalupo A, et al. Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin. Leukemia. 2007;21(7):1436-41.
12. Sloand EM, Wu CO, Greenberg P, Young N, Barrett J. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J Clin Oncol. 2008;26(5):2505-11.
13. Passweg JR, Giagounidis AA, Simcock M, Aul C, Dobbelstein C, Stadler M, et al. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99. J Clin Oncol. 2011;29(9):303-9.
14. Yoshimi A, Baumann I, Fuhrer M, Bergsträsser E, Göbel U, Sykora KW, et al. Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia. Haematologica. 2007;92(3):397-400.
15. Hasegawa D, Manabe A, Yagasaki H, Ohtsuka Y, Inoue M, Kikuchi A, et al. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99). Pediatr Blood Cancer. 2009;53(6):1011-5.
16. Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365(5):430-8.
17. Atta EH, Dias DS, Marra VL, de Azevedo AM. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol. 2010;89(9):851-9.
18. Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, et al. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood. 2012(23); 119:5391-6.
19. Yoshimi A, Niemeyer CM, Fuhrer MM, Strahm B. Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood. 2013;121(5):860-1.
20. Afable MG, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, et al. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica. 2011;96(9): 1269-75.
21. Chang MH, Kim KH, Kim HS, Jun HJ, Kim DH, Jang JH, et al. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia. Eur J Haematol. 2010;84(2):154-9.
22. Vallejo C, Colado E, Montesinos P, Rossel A, and Xicoy B. Comparison between lymphoglobulin-and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anaemia [abstract]. Bone Marrow Transplant. 2011; 45:S25.
23. Kadia TM, Borthakur G, Garcia-Manero G, Faderl S, Jabbour E, Estrov Z, et al. Final results of the phase II study of rabbit antithymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol. 2012;157(3):312-20.
24. Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, et al. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes. Haematologica. 2006;91(5):667-70.
25. Baumann I, Fuhrer M, Behrendt S, Campr V, Csomor J, Furlan I, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012; 61(1):10-7.
26. Kardos G, Baumann I, Passmore SJ, Locatelli F, Hasle H, Schultz KR, et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood. 2003;102(6):1997-2003.
27. Fuhrer M, Rampf U, Baumann I, Faldum A, Niemeyer C, Janka-Schaub G, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood. 2005;106(6): 2102-4.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457-81.
29. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18 (6):695-706.
30. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47:583-621.
31. Mann HB, Whitney DR. On a test of whether one or two random variables ist stochastically larger than the other. Annals of Mathematical Statistics. 1947; 18:50-60.
32. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.
33. Saunthararajah Y, Nakamura R, Nam JM, Robyn J, Loberiza F, Maciejewski JP, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood. 2002;100(5):1570-4.
34. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood. 2007;109(38):3219-24.
35. Di Bona E, Rodeghiero F, Bruno B, Gabbas A, Foa P, Locasciulli A, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol. 1999;107(2):330-4.
36. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol. 2006;133(6):622-7.
37. Strahm B, Bader P, Bergstraesser E, Kremens B, De Moerloose B, Sauer M, et al. Reducedintensity conditioning for children with refractory cytopenia: results of the EWOGMDS study [abstract]. Bone Marrow Transplant. 2010;45:S49.